Floatz logo

10 assets in Sarcomatoid Renal Cell Carcinoma

Therapeutic assets addressing Sarcomatoid Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Nivolumab
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP3BB (65)
Cabozantinib
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP3BB (64)
Ipilimumab
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP3BB (64)
Clostridium Butyricum Miyairi 588
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP2B (60)
Pembrolizumab
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP2CCC (53)
Sturlimogene Erparepvec
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP2CCC (53)
Zirconium Zr 89 Girentuximab Deferoxamine
Sarcomatoid Renal Cell Carcinoma
Jonsson Comprehensive Cancer CenterP2CCC (53)
Tivozanib
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP2CCC (52)
Axitinib
Sarcomatoid Renal Cell Carcinoma
Hao ZengP1/2CC (45)
Myrciaria Dubia Prebiotic Supplement
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP1CC (41)